26th Feb 2015 15:25
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday confirmed Chairman Christopher Gent will step down from his role at the company's annual general meeting in May, and will be replaced by Philip Hampton, who joined the company as a non-executive director at the start of 2015.
Hampton will become deputy chairman from April 1, and GlaxoSmithKline said he will remain Chairman of Royal Bank of Scotland Group PLC until the end of August.
Earlier, RBS said Hampton will be replaced as its chairman by Howard Davies, who is stepping down as chairman of insurance company Phoenix Group to take that role.
GlaxoSmithKline shares were up 0.4% to 1,551.75 pence per share on Thursday afternoon.
By Joshua Warner; [email protected]; @JoshAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
RBS.LGlaxosmithkline